RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
McKesson Europe - Stock

McKesson Europe Stocks 2024

McKesson Europe Stocks

203.22 M

Ticker

CLS1.HM

ISIN

DE000CLS1001

WKN

CLS100

In 2024, McKesson Europe had 203.22 M outstanding stocks, a 0% change from the 203.22 M stocks in the previous year.

The McKesson Europe Stocks history

YEARNUMBER OF STOCKS (undefined EUR)
2022203.22
2021203.22
2020203.22
2019203.22
2018203.22
2017203.22
2016203.22
2015203.22
2014199.04
2013185.67
2012170
2011170
2010186
2009170
2008175
2007170
2006170
2005170
2004170
2003170

McKesson Europe shares outstanding

  • 3 years

  • 5 years

  • 10 years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue McKesson Europe earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates McKesson Europe's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of McKesson Europe’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating McKesson Europe's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

McKesson Europe Aktienanalyse

What does McKesson Europe do?

The McKesson Europe AG is one of the largest pharmacy and pharmaceutical trading chains in Europe and has its roots in the USA. The company was founded in 1833 by John McKesson in New York City and initially focused on the sale of medical equipment and drugs for hospitals. Since then, the company has continuously evolved and expanded. In 2007, the company merged with the German Celesio AG and subsequently operated under the name McKesson Europe AG. The company now operates with over 1,500 pharmacies in more than 15 countries and employs over 39,000 people worldwide. The business model of McKesson Europe AG focuses on the distribution of medications and health and beauty products. The company's strategy is to offer a wide range of products and services to pharmacies, consumers, and clinics. The company is divided into various business segments. Prominent examples of these business segments are wholesale and pharmaceutical manufacturing, as well as involvement in online retail, consulting services for pharmacists and clinics, and the company is also an Apple OEP contractor. The wholesale division of McKesson Europe AG is one of the largest in Europe and supplies pharmacies, clinics, and specialized retailers throughout Europe. The company relies on efficient logistics to ensure fast and smooth delivery of ordered goods. Another key area in which McKesson Europe AG operates is pharmaceutical manufacturing. The company produces medications for patients and clinics. In addition, the company is also active in the online industry and operates various online shops for medications and beauty products. The company emphasizes high product quality and fast shipping. In the field of consulting and training, McKesson Europe AG supports pharmacies and clinics in optimizing their business processes and provides assistance in patient care and improving medical services. The portfolio of McKesson Europe AG is accordingly diverse and ranges from prescription and non-prescription medications to healthcare and beauty products, as well as medical devices and aids. Overall, McKesson Europe AG is a company with a long history and a wide portfolio of products and services that relies on efficient logistics and high quality and customer satisfaction. McKesson Europe ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Stocks Details

Evaluating McKesson Europe's Shares Outstanding

McKesson Europe's shares outstanding refer to the total number of shares that are currently held by all its shareholders, including institutional investors and restricted shares held by the company’s officers and insiders. The number of shares outstanding is crucial in determining the company's market capitalization and is used by investors to assess the company’s size, financial health, and investment potential.

Year-to-Year Comparison

Tracking the changes in McKesson Europe’s shares outstanding over the years can provide investors with insights into the company's financial strategies and market valuation. An increase in shares outstanding can result from actions like issuing new shares, while a decrease can result from buybacks.

Impact on Investments

For investors, understanding McKesson Europe’s shares outstanding is essential for evaluating its earnings per share (EPS) and market valuation. A change in the number of shares outstanding can impact the EPS, which is a significant driver of stock prices and investor decisions.

Interpreting Changes in Shares Outstanding

Variances in McKesson Europe’s shares outstanding can signal shifts in the company’s financial strategy. An increase may dilute the EPS and share value, indicating potential fundraising or acquisitions. Conversely, a decrease, often due to share buybacks, can enhance share value and indicate the company’s confidence in its financial performance.

Frequently Asked Questions about McKesson Europe Stock

How many stocks are there of McKesson Europe?

The current number of stocks of McKesson Europe is 203.22 M undefined.

What does Number of Shares / OutstandingShares mean?

The outstanding shares (or issued shares) of McKesson Europe are the total number of shares issued and actively held by shareholders - both external investors and company insiders. However, these must be actual shares. may grant stock options to executives that can be converted into shares.

How has the number of shares of McKesson Europe evolved in recent years?

The number of shares of McKesson Europe has increased by 0% gestiegen compared to last year.

What does the number of shares mean for investors?

The number of shares outstanding is used to calculate key metrics such as a company's market capitalization, earnings per share (EPS), and cash flow per share (CFPS). The number of outstanding shares of a company is not static and can fluctuate greatly over time.

Why does the number of stocks fluctuate?

There are various factors that can lead to a change. McKesson Europe as a company can issue new shares, carry out stock splits or reverse splits.

Does the number of shares have an impact on the performance of McKesson Europe?

There is no tangible long-term evidence or study that stocks with a certain number of shares (regardless of Mega/Large/Mid/Small Cap) would yield significantly higher returns than others. There are occasional small studies (limited number of stocks, short investment period) that certain classes outperform or have higher risk, but none of them are 1. conclusive (cause-effect is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).

How much dividend does McKesson Europe pay?

Over the past 12 months, McKesson Europe paid a dividend of 0.83 EUR . This corresponds to a dividend yield of about 3.4 %. For the coming 12 months, McKesson Europe is expected to pay a dividend of 0.83 EUR.

What is the dividend yield of McKesson Europe?

The current dividend yield of McKesson Europe is 3.4 %.

When does McKesson Europe pay dividends?

McKesson Europe pays a quarterly dividend. This is distributed in the months of September, December, December, September.

How secure is the dividend of McKesson Europe?

McKesson Europe paid dividends every year for the past 20 years.

What is the dividend of McKesson Europe?

For the upcoming 12 months, dividends amounting to 0.83 EUR are expected. This corresponds to a dividend yield of 3.4 %.

In which sector is McKesson Europe located?

McKesson Europe is assigned to the 'Health' sector.

Wann musste ich die Aktien von McKesson Europe kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of McKesson Europe from 8/1/2022 amounting to 0.83 EUR, you needed to have the stock in your portfolio before the ex-date on 8/1/2022.

When did McKesson Europe pay the last dividend?

The last dividend was paid out on 8/1/2022.

What was the dividend of McKesson Europe in the year 2023?

In the year 2023, McKesson Europe distributed 0.83 EUR as dividends.

In which currency does McKesson Europe pay out the dividend?

The dividends of McKesson Europe are distributed in EUR.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von McKesson Europe

Our stock analysis for McKesson Europe Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of McKesson Europe Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.